Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific

Asia accounted for more than 70% of worldwide liver cancer incidence cases in 2020, with China contributing the majority. A 55.0% annual global increase in disease incidence is predicted to occur between 2020 and 2040.